Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Cell
|
December 1, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis
Carol C L Chen, Shriya Deshmukh, Selin Jessa, et al.
Cancer Cell
|
March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
Lisa Mayr, Sina Neyazi, Kallen Schwark, et al.
Cancer Discovery
|
March 3, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery
|
August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Cell
|
December 1, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis
Carol C L Chen, Shriya Deshmukh, Selin Jessa, et al.
Cancer Cell
|
March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
Lisa Mayr, Sina Neyazi, Kallen Schwark, et al.
Cancer Discovery
|
March 3, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery
|
August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Page
of 8